期刊文献+

紫杉醇联合氟尿嘧啶和顺铂方案治疗晚期胃癌 被引量:10

Paclitaxel combined with 5-fluorouracil and cisplatin in the treatment of advanced gastric cancer
在线阅读 下载PDF
导出
摘要 目的观察紫杉醇联合氟尿嘧啶及顺铂(PFC)方案治疗国人晚期胃癌的临床疗效和毒副反应。方法晚期胃癌患者25例,给予紫杉醇(PTX)50mg/m2,静滴3小时,第1、8、15天给药;氟尿嘧啶(5-FU)750mg/m2,持续静脉输注24小时,第1~5天;顺铂(CDDP)20mg/m2,静脉滴注,第1~5天,28天为1周期。分别化疗2~6周期后按WHO标准评价疗效和毒副反应。结果全组25例均可评价疗效,获得CR2例,PR11例,SD7例,PD5例,近期客观有效率52.0%,中位TTP为6.5月。主要毒副反应为骨髓抑制、恶心呕吐和脱发。结论PFC方案治疗国人晚期胃癌疗效较高,毒副反应轻,多数患者耐受良好,值得推广应用。 Objective : To evaluate the efficacy and toxicity of paclitaxel combined with 5-fluorouracil and cisplatin ( PFC ) regimen in patients with advanced gastric cancer. Methods :25 cases with advanced gastric cancer were enrolled. PTX 50mg/m^2 iv 3hr d1 , 5-FU 750mg/m^2 iv 24hr d1 - d5 and CDDP 20mg/m^2 iv d1 - d5 ;and repeated every 28 days. Results:All 25 cases were available for objective response. CR 2 cases,PR 11 eases,SD 7 cases,PD 5 cases. The overall response rates (ORR) and median TIP was 52.0% and 6. 5 months respectively. The main toxicities were bone marrow suppression, nausea/vomiting and alopecia. Conclusion:PFC regimen is a high response regimen for advanced gastric cancer with well-tolerated toxicity, which can be practiced safely.
出处 《临床肿瘤学杂志》 CAS 2005年第5期489-491,共3页 Chinese Clinical Oncology
关键词 晚期胃癌 紫杉醇 氟尿嘧啶 顺铂 化学治疗 Advanced gastric cancer Paclitaxel 5-Fluorouracil Cisplatin Chemotherapy
作者简介 通讯作者,E-mail:yiba99@yahoo.com
  • 相关文献

参考文献8

  • 1卢凯华,黄普文,张锦英,仇金荣,刘连科,朱陵君.乐沙锭联合亚叶酸钙及氟脲嘧啶治疗晚期胃癌22例报告[J].南京医科大学学报(自然科学版),2004,24(5):517-518. 被引量:4
  • 2孙秀娣,牧人,周有尚,戴旭东,乔友林,张思维,皇甫小梅,孙杰,李连弟,鲁凤珠.中国1990~1992年胃癌死亡调查分析[J].中华肿瘤杂志,2002,24(1):4-8. 被引量:168
  • 3金懋林.胃癌内科化学治疗的新进展[J].医学临床研究,2003,20(10):735-738. 被引量:68
  • 4Sasaki T,Maeda Y,Kobayashi T,et al.Standard chemotherapy for gastrointestinal malignancies based on evidence[J].Jap J Cancer Chemother,2000,27(20):166-176.
  • 5Kubota T.Theoretical basis for low-dose DDP/5-FU therapy[J].Jpn J Cancer Chemotherapy,1999,26(11):1536-1541.
  • 6Sasaki T,Maeda Y,Kobayashi T,et al.New combination therapies for gastrointestinal cancer[J].Gan To Kagaku Ryoho,2000,27(3):348-355.
  • 7Ohtsu A,Boku N,Tamura F,et al.An early phase Ⅱ study of a 3-hour infusion of paclitaxel for advanced gastric cancer[J].Am J Clin Oncol,1998,21(4):416-419.
  • 8Kim YH,Shin SW,Kim BS,et al.Paclitaxel,5-fluorouracil,and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J].Cancer,1999,85(2):295-301.

二级参考文献22

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 2Rapheal E Pollock 孙燕等(译).国际抗癌联盟临床肿瘤学手册(第7版)[M].吉林:吉林科学技术出版社,2001.141-179.
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Sasaki T, Maeda Y, Kobayashi T, et al. Standard chemotherapy for gastrointestinal malignancies based on evidence[J]. Jap J Cancer Chemother , 2000,27(20):166-176.
  • 5Findlay M, Cunningham D, Norman A, et al . A phase Ⅱ study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)[J]. Ann Oncol ,1994,5:609-616.
  • 6Cocconi G. Fluorouracil, doxorubicin,and mitomycin combination versus PELF chemotherapy in advanced gastric cancer:a prospective randomized trial of the Italian Oncology Group for Clinical Research[J]. J Clin Oncol ,1994,21(12) :2687.
  • 7Kim YH, Shin SW, Kim BS, et al . Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J]. Cancer , 1999,85:295-301.
  • 8Ajani J. Clinical update on an international phase Ⅱ/Ⅲ docetaxel trial(TAX 325)[J]. Proc Update Meeting on GIC ,2002.
  • 9Kim T, Ahn J,Lee J,et al . A phase Ⅱ trial of capecitabine( X )and cisplantin(P)in previously untreated advanced gastric cancer(AGC)[J]. Proc Am Soc Clin Oncol , 2001,20 : 166.
  • 10金懋林.抗癌新药治疗胃癌进展[A]..抗癌药物与肿瘤化学治疗进展[C].北京:科学出版社,2001.55—64.

共引文献228

同被引文献79

引证文献10

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部